The central role of CD30L/CD30 interactions in allergic rhinitis pathogenesis in mice

European Journal of Immunology

Volumn 41, Issue 10, 2011, Pages 2947-2954

  Fuchiwaki, Takafumi ^a   Sun, Xun ^a,b   Fujimura, Kenjiro ^a   Yamada, Hisakata ^a   Shibata, Kensuke ^a   Muta, Hiromi ^a   Podack, Eckhard R ^c   Kawauchi, Hideyuki ^d   Yoshikai, Yasunobu ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d SHIMANE UNIVERSITY   (Japan)

Author keywords

Allergic rhinitis animal model; CD30L; Soluble CD30 Ig; Th2 cells

Indexed keywords

CD30 ANTIGEN; CD30 LIGAND; OVALBUMIN;

ALLERGIC RHINITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; IMMUNE RESPONSE; KNOCKOUT MOUSE; LYMPHOID TISSUE; MOUSE; NASOPHARYNX; NONHUMAN; NOSE MUCOSA; PATHOGENESIS; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE SUBPOPULATION; TH2 CELL; WILD TYPE;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIGENS, CD30; CD30 LIGAND; CD4-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; EOSINOPHILS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NASAL MUCOSA; NASOPHARYNX; OVALBUMIN; RECOMBINANT FUSION PROTEINS; RHINITIS, ALLERGIC, PERENNIAL; TH2 CELLS;

EID: 80053152865     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201141423     Document Type: Article

References (38)

1. Smith, C. A., Gruss, H. J., Davis, T., Anderson, D., Farrah, T., Baker, E., Sutherland, G. R. et al., CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokine with homology to TNF. Cell 1993. 73: 1349-1360.
2. Shimozato, O., Takeda, K., Yagita, H. and Okumura, K., Expression of CD30 ligand (CD153) on murine activated T cells. Biochem. Biophys. Res. Commun. 1999. 256: 519-526.
3. Kennedy, M. K., Willis, C. R. and Armitage, R. J., Deciphering CD30 ligand biology and its role in humoral immunity. Immunology 2006. 118: 143-152.
4. Lane, P. J., Gaspal, F. M. and Kim, M. Y., Two sides of a cellular coin: CD4(+)CD3- cells regulate memory responses and lymph-node organization. Nat. Rev. Immunol. 2005. 5: 655-660.
5. Dürkop, H., Latza, U., Hummel, M., Eitelbach, F., Seed, B. and Stein, H., Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 1993. 68: 421-427.
6. Ellis, T. M., Simms, P. E., Slivnick, D. J., Jack, H. M. and Fisher, R. I., CD30 is a signal-transducing molecule that defines a subset of human activated CD45RO+ T cells. J. Immunol. 1993. 151: 2380-2389.
7. Bowen, M. A., Lee, R. K., Miragliotta, G., Nam, S. Y. and Podack, E. R., Structure and expression of murine CD30 and its role in cytokine production. J. Immunol. 1996. 156: 442-449.
8. Siegmund, T., Armitage, N., Wicker, L. S., Peterson, L. B., Todd, J. A. and Lyons, P. A., Analysis of the mouse CD30 gene: a candidate for the NOD mouse type 1 diabetes locus Idd9.2. Diabetes 2000. 49: 1612-1616.
9. Florido, M., Borges, M., Yagita, H. and Appelberg, R., Contribution of CD30/CD153 but not of CD27/CD70, CD134/OX40L, or CD137/4-1BBL to the optimal induction of protective immunity to Mycobacterium avium. J. Leukoc. Biol. 2004. 76: 1039-1046.
10. Polte, T., Behrendt, A. K. and Hansen, G., Direct evidence for a critical role of CD30 in the development of allergic asthma. J. Allergy. Clin. Immunol. 2006. 118: 942-948.
11. Blazar, B. R., Levy, R. B., Mak, T. W., Panoskaltsis-Mortari, A., Muta, H., Jones, M., Roskos, M. et al., CD30/CD30 ligand (CD153) interaction regulates CD4+ T cell-mediated graft-versus-host disease. J. Immunol. 2004. 173: 2933-2941.
12. Sun, X., Somada, S., Shibata, K., Muta, H., Yamada, H., Yoshihara, H., Honda, K. et al., A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice. Gastroenterology 2008. 134: 447-458.
13. Tang, C., Yamada, H., Shibata, K., Muta, H., Wajjwalku, W., Podack, E. R. and Yoshikai, Y., A novel role of CD30L/CD30 signaling by T-T cell interaction in Th1 response against mycobacterial infection. J. Immunol. 2008. 181: 6316-6327.
14. Sun, X., Yamada, H., Shibata, K., Muta, H., Tani, K., Podack, E. R., Iwakura, Y. and Yoshikai, Y., A critical role of CD30 ligand in TH17 differentiation. J. Immunol. 2010. 185: 2222-2230.
15. Sun, X., Yamada, H., Shibata, K., Muta, H., Tani, K., Podack, E. R., Iwakura, Y. and Yoshikai, Y., CD30 ligand is a target for a novel biological therapy against colitis associated with Th17 responses. J. Immunol. 2010. 185: 7671-7680.
16. Salib, R. J., Drake-Lee, A. and Howarth, P. H., Allergic rhinitis: past, present and the future. Clin. Otolaryngol. 2003. 28: 291-303.
17. Skoner, D. P., Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J. Allergy Clin. Immunol. 2001. 108: S2-S8.
18. Borish, L., Allergic rhinitis: systemic inflammation and implications for management. J Allergy Clin. Immunol. 2003. 112: 1021-1031.
19. Gelfand, E. W., Inflammatory mediators in allergic rhinitis. J. Allergy Clin. Immunol. 2004. 114: S135-S138.
20. Hamelmann, E., Tadeda, K., Oshiba, A. and Gelfand, E.W., Role of IgE in the development of allergic airway inflammation and airway hyperresponsiveness: a murine model. Allergy. 1999. 54: 297-305.
21. Holt, P., Macaubas, G. C., Stumbles, P. A. and Sly, P. D., The role of allergy in the development of asthma. Nature 1999. 402: 12-17.
22. Kiyono, H. and Fukuyama, S., NALT- versus Peyer's-patch-mediated mucosal immunity. Nat. Rev. Immunol. 2004. 4: 699-710.
23. Hiroi, T., Iwatani, K., Iijima, H., Kodama, S., Yanagita, M. and Kiyono, H., Nasal immune system: distinctive Th0 and Th1/Th2 type environments in murine nasal-associated lymphoid tissues and nasal passage, respectively. Eur. J. Immunol. 1998. 28: 3346-3353.
24. Yanagita, M., Hiroi, T., Kitagaki, N., Hamada, S., Ito, H. O., Shimauchi, H., Murakami, S. et al., Nasopharyngeal-associated lymphoreticular tissue (NALT) immunity: fimbriae-specific Th1 and Th2 cell-regulated IgA responses for the inhibition of bacterial attachment to epithelial cells and subsequent inflammatory cytokine production. J. Immunol. 1999. 162: 3559-3565.
25. Aoi, N., Masuda, T., Murakami, D., Yajima, T., Mizubuchi, H., Kawauchi, H. and Yoshikai, Y., Interleukin-15 prevents allergic rhinitis though activation of antigen-specific CD8+ T cells. J. Allergy Clin. Immunol. 2006. 117: 1359-1366.
26. Takamura, K., Fukuyama, S., Nagatake, T., Kim, D.-Y., Kawamura, A., Kawauchi, H., and Kiyono, H., Regulatory role of lymphoid chemokine CCL19 and CCL21 in the control of allergic rhinitis. J. Immunol. 2007. 179: 5897-5906.
27. Hiromura, Y., Kishida, T., Nakano, H., Ham, T., Imanishi, J., Hisa, Y., and Mazda, O., IL-21 adminstration into the nostril alleviate murine allergic rhinitis. J. Immunol. 2007. 179: 7157-7165.
28. Frezzolini, A., Paradisi, M., Ruffelli, M., Cadoni, S. and De Pità, O., Soluble CD30 in pediatric patients with atopic dermatitis. Allergy 1997. 52: 106-109.
29. Yamamoto, J., Adachi, Y., Onoue, Y., Kanegane, H., Miyawaki, T., Toyoda, M., Seki, T. and Morohashi, M., CD30 expression on circulating memory CD4+ T cells as a Th2-dominated situation in patients with atopic dermatitis. Allergy 2000. 55: 1011-1018.
30. Kroczek, R. and Hamelmann, E., T-cell costimulatory molecules: optimal targets for the treatment of allergic airway disease with monoclonal antibodies. J. Allergy Clin. Immunol. 2005. 116: 906-909.
31. Polte, T., Fuchs, L., Behrendt, A. K. and Hansen, G., Different role of CD30 in the development of acute and chronic airway inflammation in a murine asthma model. Eur. J. Immunol. 2009. 39: 1736-1742.
32. Harlin, H., Podack, E., Boothby, M. and Alegre, M. L., TCR-independent CD30 signaling selectively induces IL-13 production via a TNF receptor-associated factor/p38 mitogen-activated protein kinase-dependent mechanism. J. Immunol. 2002. 169: 2451-2459.
33. Lee, S. Y., CD30/TNF receptor-associated factor interaction: NF-kB activation and binding specificity. Proc. Natl. Acad. Sci. USA 1996. 93: 9699-9703.
34. Duckett, C. S., Gedrich, R. W., Gilfillan, M. C. and Thompson, C. B., Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2. Mol. Cell. Biol. 1997. 17: 1535-1542.
35. Fischer, M., Harvima, I. T., Carvalho, R. F., Möller, C., Naukkarinen, A., Enblad, G. and Nilsson, G., Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulation-independent chemokine secretion. J. Clin. Invest. 2006. 116: 2748-2756.
36. Nishimura, H., Yajima, T., Muta, H., Podack, E. R., Tani, K. and Yoshikai, Y., A novel role of CD30/CD30 ligand signaling in the generation of long-lived memory CD8+T cells. J. Immunol. 2005. 175: 4627-4634.
37. Sugimoto, Y., Kawamoto, E., Chen, Z. and Kamei, C., A new model of allergic rhinitis in rats by topical sensitization and evaluation of H1-receptor antagonists. Immunopharmacology 2000. 48:1-7.
38. Asanuma, H., Inaba, Y., Aizawa, C., Kurata, T. and Tamura, S., Characterization of mouse nasal lymphocytes isolated by enzymatic extraction with collagenase. J. Immunol. Methods 1995. 187: 41-51.